ELVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 29.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $32,649,342.39

Enliven Therapeutics Insider Trading History Chart

Enliven Therapeutics Share Price & Price History

^$16.53

▲ +0.46 (2.86%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Enliven Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/7/2025	Anish Patel	COO	Sell	6,667	$18.04	$120,272.68	316,643
3/27/2025	Benjamin Hohl	CFO	Sell	3,250	$21.33	$69,322.50	23,000
3/24/2025	Benjamin Hohl	CFO	Sell	1,000	$22.50	$22,500.00	23,000
3/19/2025	Joseph P. Lyssikatos	Insider	Sell	12,500	$20.61	$257,625.00	1,002,688
3/17/2025	Samuel Kintz	CEO	Sell	12,500	$20.83	$260,375.00	990,392
3/7/2025	Anish Patel	COO	Sell	6,667	$21.44	$142,940.48	323,310
2/27/2025	Benjamin Hohl	CFO	Sell	3,250	$20.41	$66,332.50	13,000
2/7/2025	Anish Patel	COO	Sell	6,667	$21.93	$146,207.31	329,977
2/5/2025	Benjamin Hohl	CFO	Sell	1,000	$22.52	$22,520.00	13,000
1/27/2025	Benjamin Hohl	CFO	Sell	3,250	$21.59	$70,167.50	13,000
1/7/2025	Anish Patel	COO	Sell	21,700	$24.18	$524,706.00
1/3/2025	Benjamin Hohl	CFO	Sell	1,000	$25.04	$25,040.00	13,000
12/30/2024	Benjamin Hohl	CFO	Sell	900	$22.51	$20,259.00
12/27/2024	Benjamin Hohl	CFO	Sell	3,350	$22.15	$74,202.50
11/27/2024	Benjamin Hohl	CFO	Sell	5,250	$24.89	$130,672.50
10/28/2024	Benjamin Hohl	CFO	Sell	6,250	$28.56	$178,500.00
10/18/2024	Anish Patel	COO	Sell	716	$30.00	$21,480.00	343,311
10/18/2024	Benjamin Hohl	CFO	Sell	814	$30.00	$24,420.00
10/18/2024	Joseph P. Lyssikatos	Insider	Sell	847	$30.00	$25,410.00	1,015,188
10/18/2024	Richard A. Heyman	Director	Sell	817	$30.00	$24,510.00	123,673
10/18/2024	Samuel Kintz	CEO	Sell	924	$30.00	$27,720.00	1,002,892
10/15/2024	Richard A. Heyman	Director	Sell	1,270	$27.67	$35,140.90	124,490
10/9/2024	Joseph P. Lyssikatos	Insider	Sell	37,878	$28.16	$1,066,644.48	1,016,035
10/9/2024	Samuel Kintz	CEO	Sell	16,710	$28.15	$470,386.50	1,003,816
10/8/2024	Rahul D. Ballal	Director	Sell	10,420	$28.17	$293,531.40	22,341
10/7/2024	Benjamin Hohl	CFO	Sell	1,270	$27.51	$34,937.70
10/7/2024	Joseph P. Lyssikatos	Insider	Sell	2,707	$27.61	$74,740.27	1,067,180
10/7/2024	Samuel Kintz	CEO	Sell	2,730	$27.50	$75,075.00	1,033,793
10/4/2024	Benjamin Hohl	CFO	Sell	10,218	$27.51	$281,097.18
10/4/2024	Joseph P. Lyssikatos	Insider	Sell	7,522	$27.51	$206,930.22	1,069,887
10/4/2024	Richard A. Heyman	Director	Sell	2,825	$27.51	$77,715.75	125,760
10/4/2024	Samuel Kintz	CEO	Sell	12,206	$27.51	$335,787.06	1,036,523
10/1/2024	Joseph P. Lyssikatos	Insider	Sell	527	$27.54	$14,513.58	1,077,409
10/1/2024	Richard A. Heyman	Director	Sell	518	$27.54	$14,265.72	128,585
10/1/2024	Samuel Kintz	CEO	Sell	526	$27.54	$14,486.04	1,048,729
9/30/2024	Benjamin Hohl	CFO	Sell	2,000	$25.33	$50,660.00
9/27/2024	Benjamin Hohl	CFO	Sell	4,250	$24.27	$103,147.50
8/29/2024	Joseph P. Lyssikatos	Insider	Sell	12,000	$22.49	$269,880.00	1,077,936
8/27/2024	Benjamin Hohl	CFO	Sell	4,250	$22.54	$95,795.00
8/26/2024	Samuel Kintz	CEO	Sell	12,000	$22.89	$274,680.00	1,049,255
8/15/2024	Richard A. Heyman	Director	Sell	1,270	$23.25	$29,527.50	130,373
7/31/2024	Benjamin Hohl	CFO	Sell	991	$27.53	$27,282.23
7/31/2024	Joseph P. Lyssikatos	Insider	Sell	3,099	$27.56	$85,408.44	1,089,936
7/31/2024	Richard A. Heyman	Director	Sell	1,702	$27.51	$46,822.02	131,643
7/31/2024	Samuel Kintz	CEO	Sell	2,270	$27.56	$62,561.20	1,061,255
7/29/2024	Benjamin Hohl	CFO	Sell	5,250	$26.68	$140,070.00
7/29/2024	Joseph P. Lyssikatos	Insider	Sell	12,000	$26.70	$320,400.00	1,093,035
7/25/2024	Samuel Kintz	CEO	Sell	12,000	$24.92	$299,040.00	1,063,525
7/15/2024	Anish Patel	COO	Sell	30,978	$25.05	$775,998.90	345,574
7/15/2024	Richard A. Heyman	Director	Sell	1,270	$24.80	$31,496.00	133,345
7/12/2024	Anish Patel	COO	Sell	17,475	$25.07	$438,098.25	376,552
7/12/2024	Benjamin Hohl	CFO	Sell	3,000	$25.07	$75,210.00
6/27/2024	Benjamin Hohl	CFO	Sell	4,250	$22.57	$95,922.50
6/25/2024	Samuel Kintz	CEO	Sell	12,000	$21.66	$259,920.00	1,075,525
6/6/2024	Anish Patel	COO	Sell	1,133	$20.06	$22,727.98
5/28/2024	Benjamin Hohl	CFO	Sell	4,250	$23.18	$98,515.00
5/28/2024	Samuel Kintz	CEO	Sell	12,000	$23.18	$278,160.00
5/16/2024	Rishi Gupta	Director	Sell	1,033,300	$22.14	$22,877,262.00	254,814
5/14/2024	Anish Patel	COO	Sell	1,107	$25.00	$27,675.00
5/9/2024	Anish Patel	COO	Sell	260	$25.06	$6,515.60
5/6/2024	Anish Patel	COO	Sell	4,875	$22.72	$110,760.00
5/3/2024	Benjamin Hohl	CFO	Sell	1,000	$22.50	$22,500.00
4/29/2024	Benjamin Hohl	CFO	Sell	3,250	$16.97	$55,152.50
4/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$17.92	$215,040.00
4/25/2024	Samuel Kintz	CEO	Sell	12,000	$16.89	$202,680.00
4/15/2024	Richard A. Heyman	Director	Sell	1,270	$19.99	$25,387.30	137,155
4/11/2024	Anish Patel	COO	Sell	17,500	$25.03	$438,025.00
4/11/2024	Benjamin Hohl	CFO	Sell	14,000	$24.72	$346,080.00
4/11/2024	Joseph P. Lyssikatos	insider	Sell	30,000	$25.04	$751,200.00
4/11/2024	Rahul D. Ballal	Director	Sell	53,400	$23.95	$1,278,930.00	22,341
4/11/2024	Samuel Kintz	CEO	Sell	47,709	$25.04	$1,194,633.36
4/8/2024	Anish Patel	COO	Sell	4,875	$18.60	$90,675.00	2,597
4/4/2024	Rahul D. Ballal	Director	Sell	3,485	$19.15	$66,737.75	22,341
4/1/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$18.60	$223,200.00
4/1/2024	Rahul D. Ballal	Director	Sell	3,237	$19.08	$61,761.96	22,341
3/27/2024	Benjamin Hohl	CFO	Sell	3,250	$18.25	$59,312.50
3/25/2024	Samuel Kintz	CEO	Sell	12,000	$17.56	$210,720.00
3/19/2024	Richard A. Heyman	Director	Sell	1,270	$14.50	$18,415.00	143,470
3/6/2024	Anish Patel	COO	Sell	4,875	$15.64	$76,245.00	7,472
2/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$16.42	$197,040.00
2/27/2024	Benjamin Hohl	CFO	Sell	3,250	$16.97	$55,152.50
2/15/2024	Richard A. Heyman	Director	Sell	1,270	$17.42	$22,123.40	144,740
2/6/2024	Anish Patel	COO	Sell	4,875	$15.11	$73,661.25	12,347
1/31/2024	5Am Partners Vi, Llc	Major Shareholder	Sell	500,000	$15.00	$7,500,000.00	771,983
1/30/2024	Richard A. Heyman	Director	Sell	1,270	$16.41	$20,840.70	146,010
1/29/2024	Benjamin Hohl	CFO	Sell	3,250	$15.81	$51,382.50
1/29/2024	Joseph P. Lyssikatos	insider	Sell	12,000	$15.85	$190,200.00
1/25/2024	Samuel Kintz	CEO	Sell	12,000	$15.69	$188,280.00
1/22/2024	Anish Patel	COO	Sell	4,875	$15.13	$73,758.75	17,222
1/2/2024	Anish Patel	COO	Sell	11,000	$15.00	$165,000.00	22,097
1/2/2024	Benjamin Hohl	CFO	Sell	9,383	$15.01	$140,838.83
12/26/2023	Anish Patel	COO	Sell	102	$15.01	$1,531.02	35,637
12/26/2023	Benjamin Hohl	CFO	Sell	100	$15.00	$1,500.00
12/26/2023	Samuel Kintz	CEO	Sell	12,000	$14.64	$175,680.00
12/22/2023	Anish Patel	COO	Sell	983	$15.03	$14,774.49	35,739
12/22/2023	Benjamin Hohl	CFO	Sell	1,030	$15.07	$15,522.10
12/22/2023	Samuel Kintz	CEO	Sell	8,175	$13.05	$106,683.75
12/21/2023	Joseph P. Lyssikatos	insider	Sell	20	$13.00	$260.00
12/21/2023	Richard A. Heyman	Director	Sell	7	$13.00	$91.00	147,448
12/20/2023	Samuel Kintz	CEO	Sell	7,779	$13.01	$101,204.79
12/19/2023	Joseph P. Lyssikatos	insider	Sell	200	$13.00	$2,600.00
12/19/2023	Richard A. Heyman	Director	Sell	255	$13.00	$3,315.00	149,565
11/3/2023	Joseph P. Lyssikatos	insider	Sell	8,546	$13.08	$111,781.68
11/3/2023	Samuel Kintz	CEO	Sell	8,026	$13.08	$104,980.08
9/29/2023	Joseph P. Lyssikatos	insider	Sell	12,000	$13.62	$163,440.00
9/26/2023	5Am Partners Vi, Llc	Major Shareholder	Sell	197,500	$15.00	$2,962,500.00	854,796
9/25/2023	Samuel Kintz	CEO	Sell	12,000	$13.81	$165,720.00
8/24/2023	5Am Partners Vi, Llc	Major Shareholder	Sell	440,000	$16.00	$7,040,000.00	887,507

See Full Table

SEC Filings (Institutional Ownership Changes) for Enliven Therapeutics (NASDAQ:ELVN)

95.08% of Enliven Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enliven Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	Exchange Traded Concepts LLC	6,055	$0.12M	0.0%	-19.1%	0.012%
4/8/2025	Rhumbline Advisers	52,502	$1.03M	0.0%	+4.9%	0.107%
4/7/2025	GAMMA Investing LLC	2,716	$53K	0.0%	+3,058.1%	0.006%
3/24/2025	Wellington Management Group LLP	80,916	$1.82M	0.0%	+15.3%	0.165%
3/18/2025	California State Teachers Retirement System	20,914	$0.47M	0.0%	+10.2%	0.043%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	43,714	$0.98M	0.0%	+67.1%	0.089%
2/17/2025	Soleus Capital Management L.P.	75,405	$1.70M	0.1%	-68.5%	0.154%
2/17/2025	Two Sigma Investments LP	14,620	$0.33M	0.0%	-33.8%	0.030%
2/17/2025	Stempoint Capital LP	96,716	$2.18M	0.5%	N/A	0.198%
2/17/2025	Polar Capital Holdings Plc	2,389,668	$53.77M	0.3%	+267.6%	4.891%
2/17/2025	ProShare Advisors LLC	12,229	$0.28M	0.0%	+29.5%	0.025%
2/17/2025	Patient Square Capital LP	224,038	$5.04M	1.9%	+147.4%	0.459%
2/17/2025	Nicholas Investment Partners LP	157,635	$3.55M	0.3%	-9.3%	0.323%
2/17/2025	Millennium Management LLC	50,804	$1.14M	0.0%	+108.6%	0.104%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	20,036	$0.45M	0.0%	+3.7%	0.041%
2/17/2025	Janus Henderson Group PLC	1,331,877	$30M	0.0%	+27.9%	2.726%
2/17/2025	Graham Capital Management L.P.	15,178	$0.34M	0.0%	+67.3%	0.031%
2/17/2025	Deutsche Bank AG	30,516	$0.69M	0.0%	+51.7%	0.062%
2/17/2025	Brevan Howard Capital Management LP	10,144	$0.23M	0.0%	N/A	0.021%
2/17/2025	Bank of America Corp DE	34,187	$0.77M	0.0%	-29.8%	0.070%
2/17/2025	BNP Paribas Financial Markets	4,991	$0.11M	0.0%	N/A	0.010%
2/17/2025	Ameriprise Financial Inc.	35,059	$0.79M	0.0%	N/A	0.072%
2/17/2025	Ally Bridge Group NY LLC	141,710	$3.19M	2.7%	-39.7%	0.290%
2/17/2025	5AM Venture Management LLC	1,629,765	$36.67M	8.8%	-7.0%	3.336%
2/17/2025	Acuta Capital Partners LLC	267,368	$6.02M	6.1%	-9.8%	0.547%
2/14/2025	Boxer Capital Management LLC	671,358	$15.11M	1.3%	N/A	1.374%
2/14/2025	RA Capital Management L.P.	848,986	$19.10M	0.3%	-20.0%	1.738%
2/14/2025	Northern Trust Corp	331,500	$7.46M	0.0%	+8.9%	0.678%
2/14/2025	Artia Global Partners LP	102,900	$2.32M	0.8%	N/A	0.211%
2/14/2025	Boothbay Fund Management LLC	104,890	$2.36M	0.1%	-21.0%	0.215%
2/14/2025	Virtus ETF Advisers LLC	3,091	$70K	0.0%	-26.2%	0.006%
2/14/2025	Lord Abbett & CO. LLC	386,211	$8.69M	0.0%	+20.3%	0.790%
2/14/2025	Voya Investment Management LLC	10,702	$0.24M	0.0%	-8.1%	0.022%
2/14/2025	Adage Capital Partners GP L.L.C.	650,000	$14.63M	0.0%	-18.8%	1.330%
2/14/2025	Price T Rowe Associates Inc. MD	13,627	$0.31M	0.0%	+17.0%	0.028%
2/14/2025	Tower Research Capital LLC TRC	1,598	$36K	0.0%	+230.2%	0.003%
2/14/2025	MetLife Investment Management LLC	21,746	$0.49M	0.0%	+6.3%	0.045%
2/13/2025	Marshall Wace LLP	41,382	$0.93M	0.0%	-70.0%	0.085%
2/13/2025	Barclays PLC	64,563	$1.45M	0.0%	+14.8%	0.132%
2/13/2025	Legal & General Group Plc	21,140	$0.48M	0.0%	-2.9%	0.043%
2/13/2025	Invesco Ltd.	15,072	$0.34M	0.0%	+3.5%	0.031%
2/13/2025	FMR LLC	6,495,871	$146.16M	0.0%	+3.2%	13.295%
2/13/2025	Federated Hermes Inc.	117,552	$2.65M	0.0%	N/A	0.241%
2/13/2025	Wells Fargo & Company MN	16,666	$0.38M	0.0%	+49.9%	0.034%
2/12/2025	ExodusPoint Capital Management LP	8,900	$0.20M	0.0%	N/A	0.018%
2/12/2025	Geode Capital Management LLC	762,718	$17.17M	0.0%	+1.7%	1.561%
2/12/2025	Wellington Management Group LLP	80,916	$1.82M	0.0%	+15.3%	0.166%
2/12/2025	Pictet Asset Management Holding SA	972,293	$21.88M	0.0%	+16.3%	1.990%
2/12/2025	JPMorgan Chase & Co.	19,745	$0.44M	0.0%	-5.1%	0.040%
2/11/2025	Corebridge Financial Inc.	17,500	$0.39M	0.0%	-7.0%	0.036%
2/11/2025	Vanguard Group Inc.	1,975,655	$44.45M	0.0%	+2.9%	4.044%
2/11/2025	KLP Kapitalforvaltning AS	4,300	$97K	0.0%	N/A	0.009%
2/11/2025	Intech Investment Management LLC	16,322	$0.37M	0.0%	N/A	0.033%
2/10/2025	Swiss National Bank	41,873	$0.94M	0.0%	+13.9%	0.086%
2/6/2025	Charles Schwab Investment Management Inc.	261,888	$5.89M	0.0%	+2.6%	0.536%
2/4/2025	Bank of New York Mellon Corp	89,575	$2.02M	0.0%	-0.9%	0.183%
1/31/2025	New York State Common Retirement Fund	25,023	$0.56M	0.0%	-9.0%	0.051%
1/29/2025	Legato Capital Management LLC	13,492	$0.30M	0.0%	-7.5%	0.028%
1/24/2025	China Universal Asset Management Co. Ltd.	10,360	$0.23M	0.0%	+14.0%	0.021%
1/17/2025	SG Americas Securities LLC	16,629	$0.37M	0.0%	+66.1%	0.034%
12/13/2024	Lord Abbett & CO. LLC	321,055	$8.20M	0.0%	N/A	0.657%
11/27/2024	Franklin Resources Inc.	20,151	$0.56M	0.0%	N/A	0.041%
11/19/2024	Barclays PLC	56,217	$1.44M	0.0%	+295.8%	0.115%
11/16/2024	Geode Capital Management LLC	750,208	$19.16M	0.0%	+9.9%	1.588%
11/15/2024	Barclays PLC	56,217	$1.44M	0.0%	+295.8%	0.119%
11/15/2024	Jane Street Group LLC	30,793	$0.79M	0.0%	-41.9%	0.065%
11/15/2024	Wellington Management Group LLP	70,170	$1.79M	0.0%	+107.0%	0.149%
11/15/2024	State Street Corp	745,944	$19.05M	0.0%	+2.9%	1.579%
11/15/2024	RA Capital Management L.P.	1,061,233	$27.10M	0.3%	-50.0%	2.246%
11/15/2024	Patient Square Capital LP	90,572	$2.31M	0.9%	N/A	0.192%
11/15/2024	Ikarian Capital LLC	499,566	$12.76M	1.7%	-14.8%	1.058%
11/15/2024	Janus Henderson Group PLC	1,041,724	$26.61M	0.0%	+43.0%	2.205%
11/15/2024	HighVista Strategies LLC	112,459	$2.87M	1.0%	-6.1%	0.238%
11/14/2024	Verition Fund Management LLC	10,610	$0.27M	0.0%	N/A	0.022%
11/14/2024	Walleye Capital LLC	99,416	$2.54M	0.0%	N/A	0.210%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	26,168	$0.67M	0.0%	+12.7%	0.055%
11/14/2024	Ally Bridge Group NY LLC	234,856	$6M	3.2%	N/A	0.497%
11/14/2024	Acuta Capital Partners LLC	296,368	$7.57M	6.1%	-25.5%	0.627%
11/13/2024	FMR LLC	6,296,179	$160.80M	0.0%	+10.6%	13.328%
11/13/2024	The Manufacturers Life Insurance Company	17,282	$0.44M	0.0%	+25.6%	0.037%
11/12/2024	Charles Schwab Investment Management Inc.	255,277	$6.52M	0.0%	+10.4%	0.540%
11/7/2024	First Turn Management LLC	535,092	$13.67M	2.2%	+29.5%	1.133%
11/7/2024	Quest Partners LLC	21,117	$0.54M	0.0%	+1,226.4%	0.045%
10/25/2024	China Universal Asset Management Co. Ltd.	9,085	$0.23M	0.0%	+64.4%	0.019%
10/10/2024	Exchange Traded Concepts LLC	7,483	$0.19M	0.0%	-60.3%	0.016%
10/3/2024	SG Americas Securities LLC	10,013	$0.26M	0.0%	N/A	0.021%
8/15/2024	The Manufacturers Life Insurance Company	13,764	$0.32M	0.0%	N/A	0.029%
8/14/2024	Marshall Wace LLP	192,100	$4.49M	0.0%	N/A	0.408%
8/14/2024	Logos Global Management LP	595,000	$13.91M	1.1%	-62.2%	1.265%
8/14/2024	HighVista Strategies LLC	119,789	$2.80M	1.0%	-5.6%	0.255%
8/8/2024	First Turn Management LLC	413,243	$9.66M	1.6%	N/A	0.879%
8/8/2024	Nicholas Investment Partners LP	56,072	$1.31M	0.1%	N/A	0.119%
8/8/2024	American Century Companies Inc.	27,651	$0.65M	0.0%	+44.7%	0.059%
8/6/2024	Quest Partners LLC	1,592	$37K	0.0%	+87.3%	0.003%
8/1/2024	Rhumbline Advisers	49,627	$1.16M	0.0%	+29.9%	0.105%
7/26/2024	Bank of New York Mellon Corp	114,109	$2.67M	0.0%	+49.2%	0.243%
5/16/2024	California State Teachers Retirement System	19,141	$0.34M	0.0%	-5.8%	0.041%
5/16/2024	Janus Henderson Group PLC	713,911	$12.60M	0.0%	+74.8%	1.519%
5/16/2024	Blackstone Inc.	25,191	$0.44M	0.0%	N/A	0.054%
5/15/2024	Baker BROS. Advisors LP	114,833	$2.02M	0.0%	N/A	0.244%

Data available starting January 2016

See Full Table

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.

Today's Range

Now: $16.53

$16.07

$16.85

50 Day Range

MA: $19.77

$14.91

$22.46

52 Week Range

Now: $16.53

$13.30

$30.03

Volume

171,768 shs

Average Volume

264,426 shs

Market Capitalization

$810.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

Who are the company insiders with the largest holdings of Enliven Therapeutics?: Enliven Therapeutics' top insider investors include:
Joseph P Lyssikatos (Insider)
Samuel Kintz (CEO)
5Am Partners Vi, Llc (Major Shareholder)
Anish Patel (COO)
Rishi Gupta (Director)
Richard A Heyman (Director)
Benjamin Hohl (CFO)
Rahul D Ballal (Director)
Joseph P Lyssikatos (Insider)
Learn More about top insider investors at Enliven Therapeutics.
Who are the major institutional investors of Enliven Therapeutics?: Enliven Therapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.11%
Exchange Traded Concepts LLC — 0.01%
GAMMA Investing LLC — 0.01%
Learn More about top institutional investors of Enliven Therapeutics stock.
Which institutional investors are selling Enliven Therapeutics stock?: Within the previous quarter, ELVN stock was sold by these institutional investors:
Exchange Traded Concepts LLC
In the previous year, company insiders that have sold Enliven Therapeutics company stock include:
Joseph P Lyssikatos (Insider)
Samuel Kintz (CEO)
5Am Partners Vi, Llc (Major Shareholder)
Anish Patel (COO)
Rishi Gupta (Director)
Richard A Heyman (Director)
Benjamin Hohl (CFO)
Rahul D Ballal (Director)
Learn More investors selling Enliven Therapeutics stock.
Which institutional investors are buying Enliven Therapeutics stock?: During the previous quarter, ELVN stock was acquired by institutional investors including:
GAMMA Investing LLC
Rhumbline Advisers